TABLE 6.

Correlations between copy number variations and prognosis of heat shock proteins in pan-cancer.

Gene name	Variations	HR	95% CI	p Value	CancerType
HSP90AB1	ENSG00000096384._Del8	2.488	1.337–4.631	0.004	UCS
HSPA2	ENSG00000_Del_Gain6803.9	2.924	1.374–6.223	0.005	PAAD
HSPA8	ENSG00000_Del09971.1_Gain	29.131	2.64–321.42	0.006	KICH
HSPA12B	ENSG00000_Del3_Gain622.9	4.453	1.545–12.833	0.006	LAML
HSPA12B	ENSG00000_Del3_Gain622.9.1	4.453	1.545–12.833	0.006	LAML
HYOU1	ENSG00000_Del494_Gain8.17	29.131	2.64–321.42	0.006	KICH
HSPA5	ENSG00000044574.7	29.131	2.64–321.42	0.006	KICH
HSPA9	ENSG00000_Del13013.11	2.795	1.315–5.939	0.008	LAML
HSPA9	ENSG00000_Del13013.11	3.46	1.373–8.718	0.008	PRAD
HSPA4	ENSG00000_Del70606.1_Gain	2.795	1.315–5.939	0.008	LAML
HSPA9	ENSG00000_Del13013.11	1.927	1.154–3.217	0.012	ESCA
HSPA4	ENSG00000_Del70606.1_Gain	3.494	1.323–9.226	0.012	PRAD
HSPA1B	ENSG00000_Gain04388.6	1.317	1.044–1.661	0.02	STAD
HSPA1A	ENSG00000_Gain04389.9	1.317	1.044–1.661	0.02	STAD
HSPA1L	ENSG00000_Gain04390.9	1.317	1.044–1.661	0.02	STAD
HSPA8	ENSG00000_Del09971.1_Gain	0.587	0.371–0.927	0.022	BLCA
HSPA2	ENSG00000_Del_Gain6803.9	1.534	1.05–2.243	0.027	BRCA
HSPH1	ENSG00000_Del_Gain0694.18	0.671	0.469–0.959	0.028	LUSC
HSP90AB1	ENSG00000096384._Del8	3.645	1.097–12.108	0.035	MESO
HSP90AA1	ENSG000000808_Gain4._Del7	3.391	1.07–10.75	0.038	PRAD
HSPA4	ENSG00000_Del70606.1_Gain	1.699	1.023–2.821	0.041	CESC
HSPA5	ENSG00000044574.7	1.363	1.013–1.834	0.041	BRCA
HSPA8	ENSG00000_Del09971.1_Gain	1.944	1.019–3.709	0.044	MESO
HYOU1	ENSG00000_Del494_Gain8.17	1.986	1.02–3.867	0.044	MESO
HSPA1B	ENSG00000_Gain04388.6	1.386	1.007–1.908	0.045	ESCA
HSPA1A	ENSG00000_Gain04389.9	1.386	1.007–1.908	0.045	ESCA
HSPA1L	ENSG00000_Gain04390.9	1.386	1.007–1.908	0.045	ESCA
HSPH1	ENSG00000_Del_Gain0694.18	4.279	1.015–18.044	0.048	KIRP
HSPA13	ENSG00000_Del55304.5	1.806	1.004–3.249	0.048	CESC

HR, hazard ratio; 95%CI,95% Confidence Interval.